nelarabine as first-line treatment for t-cell all: facing the problem up-front
Published 6 years ago • 431 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
2:23
nelarabine for r/r t-cell all
-
1:43
nelarabine, peg-asparaginase and venetoclax added to hcvad in t-all/t-lbl
-
1:25
the diagnosis of early t-cell precursor (etp) all
-
2:10
safety & efficacy of nelarabine, pegylated asparaginase and venetoclax in frontline therapy of t-all
-
1:56
ibrutinib plus venetoclax for first-line treatment of cll: 4-year follow-up data
-
3:36
a.i virtanen: the man behind the quality | valio international
-
13:13
precision medicine in myeloproliferative neoplasms
-
2:32
acute lymphocytic leukemia (all) animation
-
2:15
management of adult t-all
-
1:09
nelarabine in combination with etoposide and cyclophosphamide in r/r t-all
-
3:36
ukall14: rituximab dose & reduced intensity transplant in b-all & nelarabine consolidation in t-all
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
3:37
results of the cog aall0434 trial for t-cell malignancies
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:41
an overview of the latest advances in hematology
-
4:13
front-line and r/r updates in cll from eha
-
0:44
is hsct a suitable treatment option for patients with all who have achieved undetectable bcr::abl1?
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
1:03
the growing importance of single-cell rna sequencing in hematology
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:17
the all frontier: should t-all be classed as a different disease?